What is QT Imaging's operating income?

QT Imaging's total operating income in 2025 was -$4.44 million, based on the following breakdown: Total Gross Profit: $8.58 million Total Operating Expenses: $13.02 million

QT Imaging (QTI) Financials

$2.80 -0.12 (-4.11%)

Closing price 04:00 PM Eastern

Extended Trading

$2.81 +0.01 (+0.36%)

As of 07:34 PM Eastern

Compare

Annual Income Statements for QT Imaging

This table shows QT Imaging's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-2.77	-6.10	-14	-21
Consolidated Net Income / (Loss)	-2.77	-6.10	-8.99	-21
Net Income / (Loss) Continuing Operations	-2.77	-6.10	-8.99	-21
Total Pre-Tax Income	-2.29	-6.10	-9.00	-21
Total Operating Income	-4.28	-5.01	-12	-4.44
Total Gross Profit	0.00	-0.09	2.64	8.58
Total Revenue	0.00	0.04	4.88	19
Operating Revenue	0.00	0.04	4.88	19
Total Cost of Revenue	0.00	0.13	2.24	10
Operating Cost of Revenue	-	0.13	2.24	10
Total Operating Expenses	4.28	4.91	15	13
Selling, General & Admin Expense	4.28	3.43	12	9.09
Research & Development Expense	-	1.49	3.27	3.94
Total Other Income / (Expense), net	1.99	-1.09	3.18	-17
Interest & Investment Income	1.63	-0.54	-4.50	-2.64
Other Income / (Expense), net	0.38	-0.54	7.67	-14
Income Tax Expense	0.49	0.00	-0.02	-0.00
Preferred Stock Dividends Declared	-	0.00	5.19	0.00
Basic Earnings per Share	($0.60)	($0.64)	($2.13)	($2.01)
Weighted Average Basic Shares Outstanding	6.54M	9.54M	6.66M	10.48M
Diluted Earnings per Share	($0.60)	($0.64)	($2.13)	($2.01)
Weighted Average Diluted Shares Outstanding	6.54M	9.54M	6.66M	10.48M
Weighted Average Basic & Diluted Shares Outstanding	17.95M	21.44M	27.65M	12.04M

This table shows QT Imaging's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-1.38	-1.51	-0.63	-6.43	-3.62	-3.49	-11	-4.00	-4.56	-1.39	-3.41
Consolidated Net Income / (Loss)	-1.38	-1.51	-0.63	-1.25	-3.62	-3.49	-11	-4.00	-4.56	-1.39	-3.41
Net Income / (Loss) Continuing Operations	-1.38	-1.51	-0.63	-1.25	-3.62	-3.49	-11	-4.00	-4.56	-1.39	-3.41
Total Pre-Tax Income	-1.38	-1.51	-0.63	-1.25	-3.62	-3.50	-11	-4.00	-4.56	-1.39	-3.41
Total Operating Income	-1.24	-0.81	-5.58	-2.22	-2.33	-2.05	-1.04	-1.04	-1.65	-0.70	-2.35
Total Gross Profit	0.00	-0.06	0.76	0.87	0.61	0.40	1.81	1.83	1.80	3.14	2.67
Total Revenue	0.02	0.00	1.36	1.71	0.96	0.85	2.80	3.66	4.19	8.28	6.53
Operating Revenue	0.02	0.00	1.36	1.71	0.96	0.85	2.80	3.66	4.19	8.28	6.53
Total Cost of Revenue	0.02	0.06	0.60	0.84	0.35	0.45	0.99	1.83	2.39	5.13	3.86
Operating Cost of Revenue	0.02	0.06	0.60	0.84	0.35	0.45	0.99	1.83	2.39	5.13	3.86
Total Operating Expenses	1.24	0.76	6.34	3.09	2.93	2.45	2.85	2.87	3.45	3.84	5.02
Selling, General & Admin Expense	0.93	0.35	5.70	2.17	2.01	1.68	2.00	1.97	2.52	2.60	3.30
Research & Development Expense	0.31	0.40	0.64	0.93	0.93	0.77	0.85	0.90	0.94	1.24	1.72
Total Other Income / (Expense), net	-0.13	-0.69	4.95	0.97	-1.29	-1.45	-10	-2.96	-2.91	-0.69	-1.06
Interest & Investment Income	-0.13	-0.15	-0.60	-1.10	-1.46	-1.35	-0.69	-0.38	-0.56	-1.00	-0.93
Other Income / (Expense), net	0.00	-0.54	5.55	2.07	0.16	-0.10	-9.40	-2.58	-2.34	0.31	-0.13
Basic Earnings per Share	($0.14)	($0.16)	($0.05)	($0.30)	($0.51)	($1.27)	($1.21)	($0.14)	($0.47)	($1.00)	($0.25)
Weighted Average Basic Shares Outstanding	9.54M	9.54M	13.23M	21.44M	7.16M	6.66M	9.17M	28.35M	9.60M	10.48M	13.80M
Diluted Earnings per Share	($0.14)	($0.16)	($0.05)	($0.30)	($0.51)	($1.27)	($1.21)	($0.14)	($0.47)	($1.00)	($0.25)
Weighted Average Diluted Shares Outstanding	9.54M	9.54M	13.23M	21.44M	7.16M	6.66M	9.17M	28.35M	9.60M	10.48M	13.80M
Weighted Average Basic & Diluted Shares Outstanding	8.66M	21.44M	21.44M	21.44M	21.83M	27.65M	28.44M	28.74M	11.90M	12.04M	12.04M

This table details how cash moves in and out of QT Imaging's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-0.34	-0.29	1.01	9.27
Net Cash From Operating Activities	-1.26	-2.65	-10	-8.96
Net Cash From Continuing Operating Activities	-1.26	-2.65	-10	-8.96
Net Income / (Loss) Continuing Operations	-2.77	-6.10	-8.99	-21
Consolidated Net Income / (Loss)	-2.77	-6.10	-8.99	-21
Depreciation Expense	-	0.48	0.23	0.13
Non-Cash Adjustments To Reconcile Net Income	0.63	1.31	0.11	16
Changes in Operating Assets and Liabilities, net	0.87	1.66	-1.39	-3.98
Net Cash From Investing Activities	192	-0.01	-0.09	-0.12
Net Cash From Continuing Investing Activities	192	-0.01	-0.09	-0.12
Purchase of Property, Plant & Equipment	-	-0.01	-0.09	-0.12
Net Cash From Financing Activities	-191	2.37	11	18
Net Cash From Continuing Financing Activities	-191	2.37	11	18
Repayment of Debt	-	0.56	-2.14	-15
Issuance of Debt	0.64	0.80	11	15
Issuance of Common Equity	-	1.02	1.50	18
Other Financing Activities, net	-192	0.00	1.24	0.63
Cash Interest Paid	-	0.00	0.54	0.43

This table details how cash moves in and out of QT Imaging's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	-0.20	0.13	5.46	-1.04	-3.04	-0.37	1.82	-0.97	-0.31	8.73	-3.51
Net Cash From Operating Activities	-0.44	-0.69	-5.98	-0.98	-1.85	-1.23	-3.54	-1.44	-0.88	-3.10	-3.65
Net Cash From Continuing Operating Activities	-0.44	-0.69	-5.98	-0.97	-1.86	-1.23	-3.54	-1.44	-0.88	-3.10	-3.65
Net Income / (Loss) Continuing Operations	-1.38	-1.51	-0.63	-1.25	-3.62	-3.49	-11	-4.00	-4.56	-1.39	-3.41
Consolidated Net Income / (Loss)	-1.38	-1.51	-0.63	-1.25	-3.62	-3.49	-11	-4.00	-4.56	-1.39	-3.41
Depreciation Expense	0.12	0.13	0.10	0.09	0.02	0.03	0.04	0.04	0.04	0.02	0.02
Non-Cash Adjustments To Reconcile Net Income	0.20	0.67	-1.32	-1.14	1.16	1.40	9.99	2.87	2.74	0.38	1.17
Changes in Operating Assets and Liabilities, net	0.60	0.03	-4.13	1.34	0.57	0.83	-2.43	-0.35	0.89	-2.11	-1.44
Net Cash From Investing Activities	-0.02	0.01	0.00	-0.03	-0.01	-0.05	0.00	-0.05	-	-0.08	-0.02
Net Cash From Continuing Investing Activities	-0.02	0.01	0.00	-0.03	-0.01	-0.05	0.00	-0.05	-	-0.08	-0.02
Purchase of Property, Plant & Equipment	-0.02	0.01	-	-	-0.01	-0.05	0.00	-	-	-0.08	-0.02
Net Cash From Financing Activities	0.27	0.80	11	-0.03	-1.18	0.91	5.35	0.52	0.57	12	0.16
Net Cash From Continuing Financing Activities	0.27	0.80	11	-0.03	-1.18	0.91	5.35	0.52	0.57	12	0.16
Repayment of Debt	0.27	0.00	-0.83	-0.03	-1.18	-0.09	-4.65	-0.03	-0.01	-10	-0.24
Issuance of Debt	-	0.80	11	-	-	-	10	-	5.00	-0.14	0.00
Issuance of Common Equity	-	-	0.50	-	-	1.00	0.00	0.70	-0.02	17	0.16
Other Financing Activities, net	-	-	1.24	-	-	-0.00	0.00	-0.15	0.61	0.17	0.25
Cash Interest Paid	-	0.00	0.16	0.00	0.38	0.00	0.01	0.00	0.00	0.42	0.00

This table presents QT Imaging's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024	2025
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	234	42	6.71	6.09	23
Total Current Assets	1.16	0.25	4.82	4.92	22
Cash & Equivalents	0.42	0.08	0.16	1.17	10
Restricted Cash	-	-	0.02	0.02	0.05
Accounts Receivable	-	-	0.00	0.07	5.78
Inventories, net	-	-	4.42	3.14	5.03
Prepaid Expenses	0.74	0.17	0.21	0.52	0.82
Plant, Property, & Equipment, net	0.00	0.00	0.49	0.20	0.32
Total Noncurrent Assets	232	42	1.40	0.97	0.61
Other Noncurrent Operating Assets	232	42	1.31	0.97	0.61
Total Liabilities & Shareholders' Equity	234	42	6.71	6.09	23
Total Liabilities	10	13	12	16	17
Total Current Liabilities	0.63	4.19	7.34	9.79	7.87
Short-Term Debt	0.00	0.26	0.71	4.99	0.01
Accounts Payable	0.03	0.20	1.36	0.80	3.58
Accrued Expenses	0.53	2.26	0.37	3.60	3.83
Other Current Liabilities	0.07	1.47	4.56	0.41	0.45
Total Noncurrent Liabilities	9.61	9.23	4.68	5.83	8.71
Long-Term Debt	-	-	3.24	3.86	4.58
Other Noncurrent Operating Liabilities	9.61	9.23	1.06	1.97	4.13
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-8.92	-13	-5.31	-9.54	6.45
Total Preferred & Common Equity	-8.92	-13	-5.31	-9.54	6.45
Preferred Stock	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-8.92	-13	-5.31	-9.54	6.45
Common Stock	0.00	0.00	12	22	59
Retained Earnings	-8.92	-13	-18	-32	-53

This table presents QT Imaging's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	23	13	11	6.96	11	12	12	22
Total Current Assets	0.13	11	9.49	5.78	9.81	11	11	21
Cash & Equivalents	0.12	5.62	4.58	1.54	2.99	2.02	1.72	6.90
Restricted Cash	-	0.02	0.02	0.02	0.02	0.02	0.02	0.05
Accounts Receivable	-	0.48	0.67	0.26	2.78	3.65	3.24	6.35
Inventories, net	-	4.12	3.35	3.18	2.87	3.23	5.24	6.83
Prepaid Expenses	0.01	1.20	0.87	0.78	1.15	1.74	1.07	1.07
Plant, Property, & Equipment, net	0.00	0.15	0.14	0.12	0.16	0.17	0.13	0.32
Total Noncurrent Assets	23	1.27	1.14	1.06	0.89	0.80	0.71	0.52
Other Noncurrent Operating Assets	23	1.23	1.14	1.06	0.89	0.80	0.71	0.52
Total Liabilities & Shareholders' Equity	23	13	11	6.96	11	12	12	22
Total Liabilities	12	18	17	17	31	12	21	18
Total Current Liabilities	8.93	4.37	15	5.43	5.28	6.31	13	8.53
Short-Term Debt	1.08	0.00	5.41	0.00	0.06	0.04	5.02	0.00
Accounts Payable	0.62	0.71	0.55	0.77	0.87	1.60	2.02	2.93
Accrued Expenses	4.19	2.81	4.19	3.36	3.89	4.21	5.24	5.13
Other Current Liabilities	3.04	0.50	5.09	1.28	0.42	0.43	0.44	0.47
Total Noncurrent Liabilities	2.78	13	1.67	11	26	5.65	8.45	9.70
Long-Term Debt	-	8.74	0.04	8.88	3.85	3.92	4.17	5.26
Other Noncurrent Operating Liabilities	2.78	4.66	1.64	2.30	22	1.73	4.29	4.45
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-11	-4.91	-6.16	-9.65	-20	-0.32	-9.08	3.80
Total Preferred & Common Equity	-11	-4.91	-6.16	-9.65	-20	-0.32	-9.08	3.80
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-11	-4.91	-6.16	-9.65	-20	-0.32	-9.08	3.80
Common Stock	5.06	17	22	22	23	47	43	60
Retained Earnings	-17	-22	-29	-32	-43	-47	-52	-56

This table displays calculated financial ratios and metrics derived from QT Imaging's official financial filings.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	10,559,050.00	8,659,978.00	21,825,475.00	11,902,198.00
DEI Adjusted Shares Outstanding	10,559,050.00	8,659,978.00	21,825,475.00	11,902,198.00
DEI Earnings Per Adjusted Shares Outstanding	-0.26	-0.70	-0.65	-1.77
Growth Metrics	-	-	-	-
Revenue Growth	0.00%	0.00%	11,990.20%	287.89%
EBITDA Growth	0.00%	-30.82%	15.77%	-328.70%
EBIT Growth	0.00%	-42.56%	18.90%	-309.62%
NOPAT Growth	0.00%	-17.03%	-143.15%	63.56%
Net Income Growth	0.00%	-119.84%	-47.32%	-134.65%
EPS Growth	0.00%	-6.67%	-232.81%	5.63%
Operating Cash Flow Growth	0.00%	-110.15%	-278.44%	10.70%
Free Cash Flow Firm Growth	0.00%	0.00%	-129.62%	28.80%
Invested Capital Growth	0.00%	-104.09%	-60.61%	130.22%
Revenue Q/Q Growth	0.00%	13.98%	20.85%	64.62%
EBITDA Q/Q Growth	0.00%	12.41%	-26.51%	8.75%
EBIT Q/Q Growth	0.00%	4.11%	-21.51%	8.74%
NOPAT Q/Q Growth	0.00%	13.43%	-11.31%	23.34%
Net Income Q/Q Growth	0.00%	-2.31%	-28.23%	9.06%
EPS Q/Q Growth	0.00%	12.33%	-108.82%	-133.72%
Operating Cash Flow Q/Q Growth	0.00%	-3.23%	-5.70%	-26.46%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	-210.64%	-16.63%
Invested Capital Q/Q Growth	0.00%	-109.49%	19.34%	135.17%
Profitability Metrics	-	-	-	-
Gross Margin	0.00%	-234.50%	54.11%	45.36%
EBITDA Margin	0.00%	-12,568.04%	-87.56%	-96.77%
Operating Margin	0.00%	-12,409.76%	-249.58%	-23.45%
EBIT Margin	0.00%	-13,759.20%	-92.29%	-97.46%
Profit (Net Income) Margin	0.00%	-15,113.25%	-184.16%	-111.40%
Tax Burden Percent	121.27%	100.03%	99.82%	100.00%
Interest Burden Percent	58.73%	109.81%	199.89%	114.31%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	-25.47%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-145.61%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-27.08%	0.00%	0.00%
Return on Equity (ROE)	-2.20%	-52.54%	121.01%	1,363.27%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	-975.77%
Operating Return on Assets (OROA)	0.00%	-22.83%	-70.40%	-126.73%
Return on Assets (ROA)	0.00%	-25.07%	-140.46%	-144.86%
Return on Common Equity (ROCE)	0.19%	41.63%	121.01%	1,363.27%
Return on Equity Simple (ROE_SIMPLE)	21.21%	114.81%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-3.00	-3.51	-8.52	-3.11
NOPAT Margin	0.00%	-8,686.83%	-174.71%	-16.41%
Net Nonoperating Expense Percent (NNEP)	-123.30%	120.14%	7.82%	2,023.31%
Return On Investment Capital (ROIC_SIMPLE)	-	256.37%	1,228.23%	-28.15%
Cost of Revenue to Revenue	0.00%	334.50%	45.89%	54.64%
SG&A Expenses to Revenue	0.00%	8,493.84%	236.73%	48.01%
R&D to Revenue	0.00%	3,681.42%	66.96%	20.80%
Operating Expenses to Revenue	0.00%	12,175.26%	303.69%	68.80%
Earnings before Interest and Taxes (EBIT)	-3.89	-5.55	-4.50	-18
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-3.88	-5.07	-4.27	-18
Valuation Ratios	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	11.27
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	11.27
Price to Revenue (P/Rev)	0.00	2,358.40	2.18	3.84
Price to Earnings (P/E)	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	5.21	0.00	0.00	117.07
Enterprise Value to Revenue (EV/Rev)	0.00	2,451.57	3.75	3.53
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	3.75	0.00	0.00
Leverage & Solvency	-	-	-	-
Debt to Equity	0.01	-0.74	-0.93	0.71
Long-Term Debt to Equity	0.00	-0.61	-0.40	0.71
Financial Leverage	0.01	0.19	-0.79	-0.57
Leverage Ratio	1.09	2.10	-0.86	-9.41
Compound Leverage Factor	0.64	2.30	-1.72	-10.76
Debt to Total Capital	0.89%	-288.49%	-1,274.35%	41.58%
Short-Term Debt to Total Capital	0.89%	-51.56%	-718.44%	0.08%
Long-Term Debt to Total Capital	0.00%	-236.93%	-555.91%	41.50%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	144.54%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-45.44%	388.49%	1,374.35%	58.42%
Debt to EBITDA	-0.07	-0.78	-2.07	-0.25
Net Debt to EBITDA	-0.05	-0.74	-1.79	0.32
Long-Term Debt to EBITDA	0.00	-0.64	-0.90	-0.25
Debt to NOPAT	-0.09	-1.13	-1.04	-1.48
Net Debt to NOPAT	-0.06	-1.07	-0.90	1.89
Long-Term Debt to NOPAT	0.00	-0.92	-0.45	-1.47
Altman Z-Score	3.96	-2.14	-9.54	-1.68
Noncontrolling Interest Sharing Ratio	108.73%	179.22%	0.00%	0.00%
Liquidity Ratios	-	-	-	-
Current Ratio	0.06	0.66	0.50	2.81
Quick Ratio	0.02	0.02	0.13	2.06
Cash Flow Metrics	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	26	-7.81	-5.56
Operating Cash Flow to CapEx	0.00%	-20,330.85%	-11,401.14%	-7,225.00%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	-54.62	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-54.62	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-
Asset Turnover	0.00	0.00	0.76	1.30
Accounts Receivable Turnover	0.00	0.00	142.89	6.47
Inventory Turnover	0.00	0.00	0.59	2.53
Fixed Asset Turnover	0.00	0.00	14.21	73.64
Accounts Payable Turnover	0.00	0.17	2.07	4.72
Days Sales Outstanding (DSO)	0.00	0.00	2.55	56.39
Days Inventory Outstanding (DIO)	0.00	0.00	616.15	144.15
Days Payable Outstanding (DPO)	0.00	2,096.34	175.94	77.35
Cash Conversion Cycle (CCC)	0.00	-2,096.34	442.76	123.19
Capital & Investment Metrics	-	-	-	-
Invested Capital	29	-1.17	-1.89	0.57
Invested Capital Turnover	0.00	0.00	-3.19	-28.76
Increase / (Decrease) in Invested Capital	0.00	-30	-0.71	2.46
Enterprise Value (EV)	149	99	18	67
Market Capitalization	108	95	11	73
Book Value per Share	($1.24)	($0.61)	($0.44)	$0.54
Tangible Book Value per Share	($1.24)	($0.62)	($0.44)	$0.54
Total Capital	29	-1.37	-0.69	11
Total Debt	0.26	3.94	8.84	4.59
Total Long-Term Debt	0.00	3.24	3.86	4.58
Net Debt	0.18	3.76	7.65	-5.88
Capital Expenditures (CapEx)	0.00	0.01	0.09	0.12
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-3.76	-2.00	-1.08	3.77
Debt-free Net Working Capital (DFNWC)	-3.68	-1.81	0.11	14
Net Working Capital (NWC)	-3.94	-2.52	-4.88	14
Net Nonoperating Expense (NNE)	-0.22	2.59	0.46	18
Net Nonoperating Obligations (NNO)	0.18	4.14	7.65	-5.88
Total Depreciation and Amortization (D&A)	0.02	0.48	0.23	0.13
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-4,953.50%	-22.20%	19.92%
Debt-free Net Working Capital to Revenue	0.00%	-4,495.84%	2.23%	75.20%
Net Working Capital to Revenue	0.00%	-6,242.84%	-99.96%	75.15%
Earnings Adjustments	-	-	-	-
Adjusted Basic Earnings per Share	($0.60)	($0.78)	($0.71)	($2.01)
Adjusted Weighted Average Basic Shares Outstanding	6.54M	6.54M	19.98M	10.48M
Adjusted Diluted Earnings per Share	($0.60)	($0.78)	($0.71)	($2.01)
Adjusted Weighted Average Diluted Shares Outstanding	6.54M	6.54M	19.98M	10.48M
Adjusted Basic & Diluted Earnings per Share	$0.06	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	17.95M	21.44M	27.65M	12.04M
Normalized Net Operating Profit after Tax (NOPAT)	-3.00	-3.51	-8.52	-3.11
Normalized NOPAT Margin	0.00%	-8,686.83%	-174.71%	-16.41%
Pre Tax Income Margin	0.00%	-15,109.28%	-184.48%	-111.41%
Debt Service Ratios	-	-	-	-
EBIT to Interest Expense	-168.63	0.00	0.00	0.00
NOPAT to Interest Expense	-129.68	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-168.63	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-129.68	0.00	0.00	0.00
Payout Ratios	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-3.06%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from QT Imaging's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	9,564,001.00	8,659,978.00	21,437,216.00	21,441,416.00	21,441,416.00	21,825,475.00	27,653,210.00	28,438,139.00	28,743,577.00	11,902,198.00	12,042,500.00
DEI Adjusted Shares Outstanding	9,564,001.00	8,659,978.00	21,437,216.00	21,441,416.00	21,441,416.00	21,825,475.00	27,653,210.00	28,438,139.00	28,743,577.00	11,902,198.00	12,042,500.00
DEI Earnings Per Adjusted Shares Outstanding	-0.14	-0.17	-0.03	-0.30	-0.17	-0.16	-0.40	-0.14	-0.16	-0.12	-0.28
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	17,908.50%	53,749.67%	3,777.07%	17,004.26%	105.41%	113.50%	338.52%	877.18%	133.38%
EBITDA Growth	-4.71%	21.85%	104.23%	93.72%	-91.44%	-72.59%	-15,129.90%	-5,173.01%	-84.32%	82.51%	76.40%
EBIT Growth	-16.19%	14.90%	98.31%	87.16%	-74.10%	-58.68%	-35,150.24%	-2,253.23%	-84.49%	82.00%	76.29%
NOPAT Growth	-12.84%	48.84%	-218.30%	-85.25%	-87.21%	-152.04%	81.32%	53.02%	29.01%	65.86%	-125.43%
Net Income Growth	-247.66%	-10.02%	66.62%	6.10%	-163.06%	-130.99%	-1,671.58%	-220.41%	-25.91%	60.20%	69.41%
EPS Growth	12.50%	36.00%	75.00%	-114.29%	-264.29%	-693.75%	-2,320.00%	53.33%	7.84%	21.26%	79.34%
Operating Cash Flow Growth	-51.82%	-13.76%	-501.94%	-85.28%	-316.61%	-78.97%	40.83%	-47.21%	52.53%	-152.85%	-3.34%
Free Cash Flow Firm Growth	-91.49%	0.00%	-89.05%	-86.66%	-19.87%	-102.47%	-22.65%	-128.81%	-114.31%	-306.91%	-237.55%
Invested Capital Growth	-58.15%	-104.09%	-107.64%	-123.37%	-118.89%	-60.61%	-963.51%	129.93%	30.68%	130.22%	110.90%
Revenue Q/Q Growth	674.65%	-79.92%	27,412.89%	25.83%	-44.23%	-11.42%	230.41%	30.77%	14.56%	97.40%	-21.09%
EBITDA Q/Q Growth	-3.50%	-10.09%	105.61%	-198.09%	-3,057.56%	0.75%	-388.90%	65.59%	-10.38%	90.58%	-559.60%
EBIT Q/Q Growth	-3.73%	-9.27%	97.82%	-419.13%	-1,306.92%	0.41%	-384.61%	65.34%	-10.30%	90.29%	-538.35%
NOPAT Q/Q Growth	-3.73%	34.54%	-585.53%	60.20%	-4.82%	11.87%	49.20%	-0.12%	-58.40%	57.62%	-235.47%
Net Income Q/Q Growth	-3.45%	-9.75%	58.37%	-98.68%	-189.82%	3.63%	-219.26%	64.07%	-13.89%	69.54%	-145.38%
EPS Q/Q Growth	0.00%	-14.29%	68.75%	-500.00%	-70.00%	-149.02%	4.72%	65.00%	-235.71%	-112.77%	75.00%
Operating Cash Flow Q/Q Growth	15.95%	-54.23%	-771.87%	83.61%	-88.99%	33.74%	-188.28%	59.23%	39.06%	-252.94%	-17.82%
Free Cash Flow Firm Q/Q Growth	-91.78%	79.44%	-26.09%	22.35%	-50.62%	-105.53%	2,414.53%	-145.56%	75.46%	-57.23%	-682.40%
Invested Capital Q/Q Growth	-45.57%	-109.49%	-54.56%	-192.85%	56.01%	19.34%	-923.45%	108.24%	-201.91%	135.17%	269.12%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	3.48%	-1,141.99%	55.80%	51.02%	63.32%	47.24%	64.76%	49.93%	43.00%	37.97%	40.92%
EBITDA Margin	-4,543.43%	-24,910.66%	5.08%	-3.96%	-224.35%	-251.37%	-371.94%	-97.87%	-94.30%	-4.50%	-37.61%
Operating Margin	-5,041.55%	-16,436.54%	-409.55%	-129.52%	-243.44%	-242.20%	-37.24%	-28.50%	-39.41%	-8.46%	-35.97%
EBIT Margin	-5,041.55%	-27,435.65%	-2.18%	-8.97%	-226.39%	-254.52%	-373.30%	-98.92%	-95.24%	-4.69%	-37.92%
Profit (Net Income) Margin	-5,580.32%	-30,499.92%	-46.15%	-72.86%	-378.62%	-411.89%	-398.00%	-109.35%	-108.71%	-16.77%	-52.16%
Tax Burden Percent	100.00%	100.11%	100.00%	100.00%	100.00%	99.54%	100.00%	100.07%	100.00%	99.73%	100.00%
Interest Burden Percent	110.69%	111.05%	2,121.39%	811.89%	167.24%	162.57%	106.62%	110.47%	114.14%	358.84%	137.56%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-5.95%	-33.73%	-36.45%	-32.31%	-137.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-151.19%	-77.30%	138.44%	0.90%	-185.14%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-2.55%	-14.37%	28.51%	0.11%	-864.29%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-8.51%	-48.10%	-7.94%	-32.20%	-1,001.30%	121.01%	155.19%	686.18%	247.57%	1,363.27%	162.76%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-718.60%	0.00%	-975.77%	-1,208.51%
Operating Return on Assets (OROA)	-5.50%	-45.51%	-0.13%	-1.29%	-60.73%	-194.13%	-198.74%	-72.92%	-114.77%	-6.10%	-52.24%
Return on Assets (ROA)	-6.09%	-50.60%	-2.85%	-10.44%	-101.57%	-314.16%	-211.89%	-80.60%	-131.00%	-21.81%	-71.86%
Return on Common Equity (ROCE)	4.64%	38.11%	5.95%	34.73%	11,941.30%	121.01%	155.19%	686.18%	247.57%	1,363.27%	162.76%
Return on Equity Simple (ROE_SIMPLE)	51.94%	0.00%	98.58%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-0.87	-0.57	-3.91	-1.55	-1.63	-1.44	-0.73	-0.73	-1.16	-0.49	-1.64
NOPAT Margin	-3,529.09%	-11,505.58%	-286.68%	-90.67%	-170.41%	-169.54%	-26.07%	-19.95%	-27.59%	-5.92%	-25.18%
Net Nonoperating Expense Percent (NNEP)	145.24%	43.57%	-174.89%	-33.21%	48.13%	34.81%	519.77%	237.14%	46.06%	101.06%	-446.06%
Return On Investment Capital (ROIC_SIMPLE)	-	41.66%	-102.09%	217.67%	210.46%	206.88%	4.48%	-20.10%	-1,009.89%	-4.44%	-18.16%
Cost of Revenue to Revenue	96.52%	1,241.99%	44.20%	48.98%	36.68%	52.76%	35.24%	50.07%	57.00%	62.03%	59.08%
SG&A Expenses to Revenue	3,780.36%	7,169.66%	418.17%	126.58%	209.97%	198.03%	71.55%	53.82%	60.02%	31.40%	50.49%
R&D to Revenue	1,264.67%	8,124.88%	47.17%	53.97%	96.78%	91.42%	30.45%	24.61%	22.39%	15.04%	26.40%
Operating Expenses to Revenue	5,045.03%	15,294.55%	465.35%	180.55%	306.76%	289.45%	102.00%	78.43%	82.41%	46.44%	76.89%
Earnings before Interest and Taxes (EBIT)	-1.24	-1.36	-0.03	-0.15	-2.16	-2.16	-10	-3.62	-3.99	-0.39	-2.48
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-1.12	-1.23	0.07	-0.07	-2.14	-2.13	-10	-3.58	-3.95	-0.37	-2.46
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	11.27	18.61
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	11.27	18.61
Price to Revenue (P/Rev)	2,920.20	2,358.40	16.29	5.10	3.77	2.18	2.63	4.59	5.91	3.84	3.12
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	10.28	0.00	0.00	0.00	0.00	0.00	0.00	25.03	0.00	117.07	32.79
Enterprise Value to Revenue (EV/Rev)	3,594.06	2,451.57	18.51	5.37	5.58	3.75	2.77	4.82	6.56	3.53	3.05
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	3.75	1.33	0.79	3.19	0.00	1.44	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.09	-0.74	-1.78	-0.88	-0.92	-0.93	-0.19	-12.20	-1.01	0.71	1.38
Long-Term Debt to Equity	0.00	-0.61	-1.78	-0.01	-0.92	-0.40	-0.19	-12.09	-0.46	0.71	1.38
Financial Leverage	0.02	0.19	0.21	0.12	4.67	-0.79	-0.16	-0.43	-0.79	-0.57	0.05
Leverage Ratio	1.57	2.10	2.48	2.78	16.99	-0.86	-0.94	-3.46	-1.02	-9.41	-2.00
Compound Leverage Factor	1.74	2.33	52.65	22.56	28.41	-1.40	-1.01	-3.82	-1.16	-33.77	-2.76
Debt to Total Capital	8.63%	-288.49%	228.47%	-762.72%	-1,146.95%	-1,274.35%	-24.01%	108.93%	8,026.13%	41.58%	58.04%
Short-Term Debt to Total Capital	8.63%	-51.56%	0.00%	-757.58%	0.00%	-718.44%	-0.39%	1.01%	4,386.37%	0.08%	0.00%
Long-Term Debt to Total Capital	0.00%	-236.93%	228.47%	-5.14%	-1,146.95%	-555.91%	-23.62%	107.92%	3,639.75%	41.50%	58.04%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	183.17%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-91.80%	388.49%	-128.47%	862.72%	1,246.95%	1,374.35%	124.01%	-8.93%	-7,926.13%	58.42%	41.96%
Debt to EBITDA	-0.19	-0.78	-2.60	-2.32	-2.63	-2.07	-0.27	-0.22	-0.46	-0.25	-0.51
Net Debt to EBITDA	-0.17	-0.74	-0.92	-0.36	-2.17	-1.79	-0.06	-0.10	-0.37	0.32	0.16
Long-Term Debt to EBITDA	0.00	-0.64	-2.60	-0.02	-2.63	-0.90	-0.26	-0.21	-0.21	-0.25	-0.51
Debt to NOPAT	-0.27	-1.13	-1.41	-0.79	-1.16	-1.04	-0.73	-0.87	-2.27	-1.48	-1.31
Net Debt to NOPAT	-0.24	-1.07	-0.50	-0.12	-0.96	-0.90	-0.17	-0.42	-1.84	1.89	0.42
Long-Term Debt to NOPAT	0.00	-0.92	-1.41	-0.01	-1.16	-0.45	-0.72	-0.87	-1.03	-1.47	-1.31
Altman Z-Score	3.66	-0.07	-0.88	-3.54	-6.30	-8.27	-7.32	-3.63	-4.32	0.91	0.09
Noncontrolling Interest Sharing Ratio	154.52%	179.22%	174.94%	207.84%	1,292.57%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.01	0.66	2.62	0.62	1.06	0.50	1.86	1.69	0.89	2.81	2.49
Quick Ratio	0.01	0.02	1.40	0.34	0.33	0.13	1.09	0.90	0.39	2.06	1.55
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	16	29	22	27	13	-0.72	17	-7.64	-1.87	-2.95	-23
Operating Cash Flow to CapEx	-1,786.79%	0.00%	0.00%	0.00%	-24,317.89%	-2,296.57%	0.00%	0.00%	0.00%	-4,018.33%	-21,494.12%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.06	0.14	0.27	0.76	0.53	0.74	1.21	1.30	1.38
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	142.89	3.87	3.82	6.57	6.47	4.96
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.59	0.75	1.10	1.34	2.53	2.72
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	14.21	39.74	53.58	92.24	73.64	94.65
Accounts Payable Turnover	0.17	0.17	1.29	3.04	2.67	2.07	3.32	3.37	4.06	4.72	6.96
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	2.55	94.35	95.45	55.57	56.39	73.58
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	616.15	486.26	332.37	271.86	144.15	133.96
Days Payable Outstanding (DPO)	2,118.08	2,096.34	282.67	119.94	136.90	175.94	110.03	108.27	89.96	77.35	52.44
Cash Conversion Cycle (CCC)	-2,118.08	-2,096.34	-282.67	-119.94	-136.90	442.76	470.59	319.55	237.47	123.19	155.10
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	12	-1.17	-1.81	-5.32	-2.34	-1.89	-19	1.59	-1.62	0.57	2.10
Invested Capital Turnover	0.00	0.00	0.13	0.36	0.80	-3.19	-0.60	-4.44	-5.81	-28.76	-2.63
Increase / (Decrease) in Invested Capital	-17	-30	-26	-28	-15	-0.71	-17	6.91	0.72	2.46	21
Enterprise Value (EV)	127	99	26	17	23	18	17	40	75	67	69
Market Capitalization	103	95	23	16	15	11	17	38	68	73	71
Book Value per Share	($1.20)	($0.61)	($0.23)	($0.29)	($0.45)	($0.44)	($0.93)	($0.01)	($0.32)	$0.54	$0.32
Tangible Book Value per Share	($1.20)	($0.62)	($0.23)	($0.29)	($0.45)	($0.44)	($0.93)	($0.01)	($0.32)	$0.54	$0.32
Total Capital	13	-1.37	3.83	-0.71	-0.77	-0.69	-16	3.63	0.11	11	9.05
Total Debt	1.08	3.94	8.74	5.45	8.88	8.84	3.91	3.96	9.19	4.59	5.26
Total Long-Term Debt	0.00	3.24	8.74	0.04	8.88	3.86	3.85	3.92	4.17	4.58	5.26
Net Debt	0.96	3.76	3.10	0.84	7.31	7.65	0.91	1.91	7.46	-5.88	-1.70
Capital Expenditures (CapEx)	0.02	-0.01	0.00	0.00	0.01	0.05	0.00	0.00	0.00	0.08	0.02
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-7.84	-2.00	1.42	-4.97	-1.22	-1.08	1.59	2.36	1.83	3.77	5.72
Debt-free Net Working Capital (DFNWC)	-7.72	-1.81	7.06	-0.36	0.34	0.11	4.59	4.40	3.57	14	13
Net Working Capital (NWC)	-8.80	-2.52	7.06	-5.77	0.34	-4.88	4.53	4.36	-1.45	14	13
Net Nonoperating Expense (NNE)	0.51	0.94	-3.28	-0.31	1.99	2.05	10	3.27	3.40	0.90	1.76
Net Nonoperating Obligations (NNO)	0.96	4.14	3.10	0.84	7.31	7.65	0.91	1.91	7.46	-5.88	-1.70
Total Depreciation and Amortization (D&A)	0.12	0.13	0.10	0.09	0.02	0.03	0.04	0.04	0.04	0.02	0.02
Debt-free, Cash-free Net Working Capital to Revenue	-22,156.99%	-4,953.50%	101.97%	-159.87%	-30.22%	-22.20%	25.13%	28.52%	15.94%	19.92%	25.25%
Debt-free Net Working Capital to Revenue	-21,812.81%	-4,495.84%	506.30%	-11.73%	8.53%	2.23%	72.76%	53.24%	31.04%	75.20%	55.93%
Net Working Capital to Revenue	-24,860.42%	-6,242.84%	506.30%	-185.87%	8.53%	-99.96%	71.76%	52.80%	-12.65%	75.15%	55.93%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.13)	($0.16)	($0.33)	($0.30)	($0.51)	($1.27)	($0.40)	($0.14)	($0.47)	($1.00)	($0.25)
Adjusted Weighted Average Basic Shares Outstanding	6.54M	9.54M	13.23M	21.44M	7.15M	6.66M	27.52M	28.35M	9.60M	10.48M	13.80M
Adjusted Diluted Earnings per Share	($0.13)	($0.16)	($0.33)	($0.30)	($0.51)	($1.27)	($0.40)	($0.14)	($0.47)	($1.00)	($0.25)
Adjusted Weighted Average Diluted Shares Outstanding	6.54M	9.54M	13.23M	21.44M	7.15M	6.66M	27.52M	28.35M	9.60M	10.48M	13.80M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	8.66M	21.44M	21.44M	21.44M	7.28M	27.65M	28.44M	28.74M	11.90M	12.04M	12.04M
Normalized Net Operating Profit after Tax (NOPAT)	-0.87	-0.57	-3.91	-1.55	-1.63	-1.44	-0.73	-0.73	-1.16	-0.49	-1.64
Normalized NOPAT Margin	-3,529.09%	-11,505.58%	-286.68%	-90.67%	-170.41%	-169.54%	-26.07%	-19.95%	-27.59%	-5.92%	-25.18%
Pre Tax Income Margin	-5,580.32%	-30,467.60%	-46.15%	-72.86%	-378.62%	-413.78%	-398.00%	-109.27%	-108.71%	-16.82%	-52.16%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

QT Imaging (NASDAQ: QTI) is showing top-line growth, but the financial statements still point to a company that is burning cash, carrying meaningful debt, and operating with thin or negative profitability. Revenue improved sharply over the past year, but losses remain large and the balance sheet has become more levered. The latest quarter also shows a significant drop in cash compared with the prior quarter, which is something investors should watch closely.

Revenue growth accelerated year over year. Q1 2026 revenue rose to $6.53 million from $2.80 million in Q1 2025 and $846,832 in Q4 2024, showing strong top-line expansion.
Gross profit improved in absolute dollars. Q1 2026 gross profit was $2.67 million, up from $1.81 million in Q1 2025 and $400,066 in Q4 2024.
Operating expenses were lower than revenue growth. SG&A and R&D combined in Q1 2026 were $5.02 million, which is still high, but materially below the revenue run-rate improvement seen over the last several quarters.
The company ended Q1 2026 with no short-term debt reported. That removes some near-term refinancing pressure versus earlier periods when short-term debt was present.
Cash from financing was positive in Q1 2026. The company brought in $159,000 from financing activities, helping partially offset operating cash burn.
Share count has been volatile. Weighted average basic shares swung from 28.35 million in Q2 2025 to 13.80 million in Q1 2026, which makes per-share comparisons harder and can dilute long-term holders.
Inventory remains a large balance sheet item. Inventory was $6.83 million in Q1 2026, suggesting working capital is still tied up in product.
Accounts receivable also increased materially. Receivables were $6.35 million in Q1 2026, which could support revenue growth but also adds collection risk if customer payments slow.
Other noncurrent operating liabilities remain sizeable. These liabilities totaled $4.45 million in Q1 2026, which adds complexity to the balance sheet.
The company remains unprofitable. Q1 2026 net loss was $3.41 million, and Q1 2025, Q2 2025, Q3 2025, and Q4 2025 were also all losses.
Operating cash flow was negative again. Q1 2026 operating cash flow was -$3.65 million, showing the business is still consuming cash to run.
Cash declined sharply quarter over quarter. Cash & equivalents fell from $1.72 million in Q3 2025 to $6.90 million in Q1 2026 after a large Q4 financing event, but operating losses quickly used up much of the cash cushion.
Debt levels remain meaningful. Q1 2026 showed $5.26 million of long-term debt and total liabilities of $18.23 million versus total equity of just $3.80 million.
Equity remains thin relative to liabilities. The company’s balance sheet is still highly leveraged, with liabilities far exceeding equity.
Interest and other non-operating items are hurting results. In Q1 2026, total other income/expense was a negative $1.06 million, which deepened the quarterly loss.

Bottom line: QTI’s recent revenue trend is encouraging, but the company is still far from consistent profitability. Investors should focus on whether revenue growth can continue while losses, cash burn, and leverage come down. Until then, the stock remains a high-risk turnaround story.

07/23/26 07:45 PM ETAI Generated. May Contain Errors.

QT Imaging Financials - Frequently Asked Questions

According to the most recent income statement we have on file, QT Imaging's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

QT Imaging's net income appears to be on an upward trend, with a most recent value of -$21.08 million in 2025, rising from -$2.77 million in 2022. The previous period was -$8.99 million in 2024. Find out what analysts predict for QT Imaging in the coming months.

QT Imaging's total operating income in 2025 was -$4.44 million, based on the following breakdown:

Total Gross Profit: $8.58 million
Total Operating Expenses: $13.02 million

Over the last 3 years, QT Imaging's total revenue changed from $0.00 in 2022 to $18.93 million in 2025, a change of 1,892,500,000.0%.

QT Imaging's total liabilities were at $16.58 million at the end of 2025, a 6.1% increase from 2024, and a 61.8% increase since 2021.

In the past 4 years, QT Imaging's cash and equivalents has ranged from $78.20 thousand in 2022 to $10.41 million in 2025, and is currently $10.41 million as of their latest financial filing in 2025.

Over the last 3 years, QT Imaging's book value per share changed from -1.24 in 2022 to 0.54 in 2025, a change of -143.7%.

Related Companies

Financial statements for NASDAQ:QTI last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

QT Imaging (QTI) Financials

Financials Breakdown Chart

Key Financial Trends

QT Imaging Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

QT Imaging (QTI) Financials

Annual Income Statements for QT Imaging

Quarterly Income Statements for QT Imaging

Annual Cash Flow Statements for QT Imaging

Quarterly Cash Flow Statements for QT Imaging

Annual Balance Sheets for QT Imaging

Quarterly Balance Sheets for QT Imaging

Annual Metrics And Ratios for QT Imaging

Quarterly Metrics And Ratios for QT Imaging

Financials Breakdown Chart

Key Financial Trends

QT Imaging Financials - Frequently Asked Questions

When does QT Imaging's fiscal year end?

How has QT Imaging's net income changed over the last 3 years?

What is QT Imaging's operating income?

How has QT Imaging's revenue changed over the last 3 years?

How much debt does QT Imaging have?

How much cash does QT Imaging have?

How has QT Imaging's book value per share changed over the last 3 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools